Exousia Bio, Inc.
LMMY· OTC
LMMYExousia Bio, Inc.
Filed Oct 17, 2025 · 10-K · 139 days after period end · 0001683168-25-007621
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022 |
|---|---|---|---|---|
| Revenue | $0.00 | $3.75K | $0.00 | $0.00 |
| Net Income | — | -$5.25K | -$26.78K | -$937.00 |
| EPS Diluted | — | — | — |
Exousia Bio, Inc. · CIK 1939937 · Engraved from SEC EDGAR
| $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended May 31, 2025 · filed Oct 17, 2025 · 139 d after period end
